Company Sprint Bioscience AB

Equities

SPRINT

SE0006343745

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per region

Annual profits - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Nasdaq Stockholm Other stock markets 16:29:54 15/05/2024 BST			5-day change	1st Jan Change
1.334 ^SEK	+9.88%		-1.91%	-23.11%

05-08	Sprint Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02-14	Sprint Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Sprint Bioscience AB is a Sweden-based drug development company. It is engaged in the development of oncology therapeutics, focusing on cancer metabolism and liquid signaling. The Company's research is based on its fragment based drug discovery (FBDD) platform, which enables rapid indentifying of molecules with properties suitable for drug development. Its pipeline is divided in two research areas: cancer metabolism and autophagy, comprising products in the phases of establishing FBDD project and in the in vivo development. The Companyâs strategy involves out-licensing or collaborating at an early stage of drug discovery in order to focus on current market needs.

Number of employees: 28

SEK in Million	2022	Weight	2023	Weight	Delta
Small Molecules Drug 100.0 %	0	100.0 %	50	100.0 %	+60,725.30%

SEK in Million	2022	Weight	2023	Weight	Delta
United States 99.9 %	0	42.2 %	50	99.9 %	+144,028.57%
Sweden 0.1 %	0	57.8 %	0	0.1 %	-14.58%

Managers	Title	Age	Since
Johan Emilsson CEO	Chief Executive Officer	40	30/09/23
Martin Andersson FOU	Founder	53	31/12/08
Mathias Skalmstad DFI	Director of Finance/CFO	51	31/12/10
Anne-Marie Wenthzel PRN	Corporate Officer/Principal	-	31/12/10

Members of the board	Title	Age	Since
Svein Arild Mathisen BRD	Director/Board Member	68	31/12/19
Björn Magnus Sjöstrand CHM	Chairman	56	31/12/20
Fredrik Lehmann BRD	Director/Board Member	48	31/12/18
Nils Rune Nordlander BRD	Director/Board Member	68	31/12/09
Karin From BRD	Director/Board Member	54	31/12/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	69,820,090	32,956,722 ( 47.20 %)	0	47.20 %

Sprint Bioscience AB

Hälsovägen 7 8th Floor, elevator A

141 57, Huddinge

+46 84 11 44 55

http://www.sprintbioscience.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
SPRINT BIOSCIENCE AB	-23.11%	7.83M
VERTEX PHARMACEUTICALS INCORPORATED	+7.48%	111B
REGENERON PHARMACEUTICALS, INC.	+11.35%	106B
BIONTECH SE	-12.47%	22.24B
ARGENX SE	+0.44%	21.25B
GENMAB A/S	-4.18%	18.97B
WUXI APPTEC CO., LTD.	-37.85%	18.52B
BEIGENE, LTD.	-8.78%	16.81B
SAREPTA THERAPEUTICS, INC.	+38.19%	12.54B
LEGEND BIOTECH CORPORATION	-24.28%	8.09B

Bio Therapeutic Drugs